Navigation Links
PositiveID Analyst Coverage Continued; Brief Report by Small Cap Traders
Date:9/10/2014

NEW YORK, Sept. 10, 2014 /PRNewswire/ -- Small Cap Traders analyst report by Michael Anderegg, CFA.  PositiveID Corp. (OTCQB: PSID) based in Delray Beach, Fla. and Pleasanton, CA is an emerging player in the BioThreat detection market and has garnered increasing attention as the recent high visibility Ebola outbreak has exploded. Since a Company update disclosing the issuance of revenue guidance through the end of 2015 of $4-10 million (combined between 2014 and 2015), the Company subsequently reported earnings in August featuring the Company's first ever revenue from operations and the smallest operating loss in Company History.  A number of metrics were hit in 1H14 that have established traction and begun to build momentum for what is expected to be a strong 2H of the year for PSID. 

In addition its Firefly Dx system, designed to deliver molecular diagnostic results rapidly at the point-of-need, which could be used to detect Ebola and other biological threats, was recently featured in Computerworld. The article titled "Mobile testing for Ebola gains renewed urgency as outbreak grows," can be found at: http://bit.ly/-PSID-ArticleComputerWorld

This morning's announcement that the Company has shipped three M-BAND (Microfluidic-based Bioagent Autonomous Networked Detector) systems to Aberdeen Proving Ground ("APG") in Maryland for continued testing to protect U.S. warfighters as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR) program. APG is recognized as one of the world's most important research and development, testing and evaluation facilities for military weapons and equipment, and supports military and civilian scientists, research engineers, technicians and administrators.  This announcement is well timed to coincide with a management presentation at the Rodman & Renshaw 16th Annual Global Investment Conference at the New York Palace Hotel.  PSID is well positioned to garner not only increasing market share but also to significantly increase visibility and awareness in the investment community.

An analyst report which details the current situation, an overview of the company and analyst comments can be viewed in its entirety by using the link below. There is no cost obligation required to view this report: 

http://bit.ly/-PSID-AnalystBrief

Copy and Paste may be required.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. Information in this release is fact checked and produced on a best efforts basis by Michael Anderegg, Chartered Financial Analyst. An outsourced research services provider represented by Michael Anderegg, CFA, provided Small Cap Traders this article or report. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. Small Cap Traders is not entitled to veto, interfere or alter the articles, documents or report once created and reviewed by the outsourced research provider represented by Michael Anderegg, CFA. The subject Company has not compensated Small Cap Traders or Michael Anderegg for the creation or dissemination of this report. Small Cap Traders is the party responsible for issuing the press release and for hosting the full analyst report on smallcapir.com. Michael Anderegg, Chartered Financial Analyst, is the author of research report. This information is submitted to increase awareness for mentioned companies to our subscriber base and the investing public.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at admin@smallcaptraders.com. For any urgent concerns or inquiries, please contact us at admin@smallcaptraders.com.

NOT FINANCIAL ADVICE

Small Cap Traders makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Small Cap Traders is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. Small Cap Traders has compensated Michael Anderegg, CFA, fifty dollars for the right to disseminate analyst report. No liability is accepted by Small Cap Traders whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap Traders expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap Traders does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


'/>"/>
SOURCE Small Cap Traders
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. POSITIVEID In Businessweek For Bid On U$5.7 Billion BIOWATCH Program
2. Sequenom to Host Analyst Day on Monday, November 14, 2011
3. Keryx Biopharmaceuticals Announces Live Webcast of Upcoming Analyst Day
4. Growing Awareness & Increasing Number of Indications Drive the Global Intravenous Immunoglobulin Market, According to a New Report by Global Industry Analysts, Inc.
5. Kitware to Improve Air Force Video Analyst Workflows with VIRAT
6. Environmental Concerns & Depleting Fossil Fuels Drive the Global Renewable Chemicals Market, According to New Report by Global Industry Analysts, Inc.
7. Global H1N1 Vaccines Market to Reach US $273 Million by 2018, According to a New Report by Global Industry Analysts, Inc.
8. The Zacks Analyst Blog Highlights: SPDR Health Care Select Sector Fund, SPDR S&P 500, SPDRS&P Biotech ETF, PowerShares S&P SmallCap Health Care Portfolio and PowerShares Dynamic Biotechnology & Genome Portfolio
9. Rising Incidence of Stroke Drives the Global Intracranial Stents Market, According to New Report by Global Industry Analysts, Inc.
10. Legislative Benefits and Unmet Needs to Drive the Market for Orphan Drugs, According to a New Report by Global Industry Analysts, Inc.
11. Global Industry Analysts, Inc. Announces the Launch of a Major Research Program Analysing the Global Market for Circulating Tumor Cells and Cancer Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):